Influence of r-type (Cav2.3) and t-type (Cav3.1–3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis-Reference-Cited by-同舟云学术

Influence of r-type (Cav2.3) and t-type (Cav3.1–3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis

Published:2003-09 Issue:3 Volume:120 Page:757-764
ISSN:0306-4522
Container-title:Neuroscience
language:en
Short-container-title:Neuroscience

Author:

Bergquist F,Nissbrandt H

Publisher

Elsevier BV

Subject

General Neuroscience

Reference54 articles.

1. R-Type Ca2+ channels are coupled to the rapid component of secretion in mouse adrenal slice chromaffin cells;Albillos;J Neurosci,2000

2. Effects of local administration of L-, N-, and P/Q-type calcium channel blockers on spontaneous dopamine release in the striatum and the substantia nigra;Bergquist;J Neurochem,1998

3. Evidence for different exocytosis pathways in dendritic and terminal dopamine release in vivo;Bergquist;Brain Res,2002

4. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967);Bezprozvanny;Mol Pharmacol,1995

5. Dopamine in dendrites of substantia nigra neurons;Björklund;Brain Res,1975

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Voltage-Gated Calcium Channels in Basal Ganglia Neurodegenerative Disorders;Current Neuropharmacology;2023-02

2. Voltage-Gated Ca2+ Channels in Dopaminergic Substantia Nigra Neurons: Therapeutic Targets for Neuroprotection in Parkinson's Disease?;Frontiers in Synaptic Neuroscience;2021-02-26

3. Neurotransmitters and Behavioral Alterations Induced by Nickel Exposure;Endocrine, Metabolic & Immune Disorders - Drug Targets;2020-09-09

4. Voltage-Gated Calcium Channels and α-Synuclein: Implications in Parkinson’s Disease;Frontiers in Molecular Neuroscience;2019-10-09

5. The Potential of L-Type Calcium Channels as a Drug Target for Neuroprotective Therapy in Parkinson's Disease;Annual Review of Pharmacology and Toxicology;2019-01-06